1. Alnylam, Cubist report progress on R&D effort
- Subjects
Alnylam Pharmaceuticals Inc. -- Research ,Cubist Pharmaceuticals Inc. -- Research ,Pharmaceutical industry -- Research ,Inhaled medication -- Usage ,Inhaled medication -- Research ,Respiratory syncytial virus -- Drug therapy ,Respiratory syncytial virus -- Research ,Respiratory tract infections -- Research ,Respiratory tract infections -- Drug therapy ,Business ,Pharmaceuticals and cosmetics industries ,Retail industry - Abstract
CAMBRIDGE, Mass. -- Alnylam Pharmaceuticals Inc. and Cubist Pharmaceuticals Inc. confirm that a midstage study of their experimental drug for a respiratory infection has met its major objective. The biopharmaceutical [...]
- Published
- 2009